Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

YTE ($INCY) Releases Q4 2025 Earnings

None

YTE ($INCY) posted quarterly earnings results for Q4 2025 on Tuesday, February 10th. The company reported earnings of $1.80 per share, missing estimates of $1.97 by $0.17. The company also reported revenue of $1,506,840,000, beating estimates of $1,378,953,198 by $127,886,802.

You can see Quiver Quantitative's $INCY stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

YTE Insider Trading Activity

INCY Insider Trades

YTE insiders have traded $INCY stock on the open market 22 times in the past 6 months. Of those trades, 0 have been purchases and 22 have been sales.

Here’s a breakdown of recent trading of $INCY stock by insiders over the last 6 months:

  • HERVE HOPPENOT sold 187,500 shares for an estimated $19,773,750
  • MICHAEL JAMES MORRISSEY (EVP, Head of Tech. Operations) has made 0 purchases and 3 sales selling 58,331 shares for an estimated $5,675,001.
  • STEVEN H STEIN (EVP & Chief Medical Officer) has made 0 purchases and 4 sales selling 43,531 shares for an estimated $4,449,228.
  • MOHAMED KHAIRIE ISSA (EVP, Head of US Oncology) sold 10,856 shares for an estimated $1,184,063
  • SHEILA A. DENTON (EVP & General Counsel) has made 0 purchases and 8 sales selling 6,406 shares for an estimated $563,158.
  • PATRICK A MAYES (EVP & Chief Scientific Officer) has made 0 purchases and 2 sales selling 5,808 shares for an estimated $554,965.
  • THOMAS TRAY (Principal Accounting Officer) has made 0 purchases and 2 sales selling 3,374 shares for an estimated $336,350.
  • LEE HEESON (EVP, Head of Incyte Intl) sold 3,074 shares for an estimated $289,017

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

YTE Hedge Fund Activity

We have seen 455 institutional investors add shares of YTE stock to their portfolio, and 311 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

YTE Analyst Ratings

Wall Street analysts have issued reports on $INCY in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • TD Cowen issued a "Buy" rating on 01/13/2026
  • Barclays issued a "Overweight" rating on 11/24/2025
  • Piper Sandler issued a "Overweight" rating on 11/04/2025
  • Guggenheim issued a "Buy" rating on 11/03/2025
  • Stifel issued a "Buy" rating on 09/22/2025
  • B of A Securities issued a "Buy" rating on 09/04/2025

To track analyst ratings and price targets for YTE, check out Quiver Quantitative's $INCY forecast page.

YTE Price Targets

Multiple analysts have issued price targets for $INCY recently. We have seen 14 analysts offer price targets for $INCY in the last 6 months, with a median target of $108.5.

Here are some recent targets:

  • Allison Bratzel from Piper Sandler set a target price of $110.0 on 02/06/2026
  • Mitchell S. Kapoor from HC Wainwright & Co. set a target price of $135.0 on 02/05/2026
  • Etzer Darout from Barclays set a target price of $116.0 on 02/04/2026
  • Derek Archila from Wells Fargo set a target price of $107.0 on 01/20/2026
  • Marc Frahm from TD Cowen set a target price of $128.0 on 01/13/2026
  • Vikram Purohit from Morgan Stanley set a target price of $94.0 on 01/06/2026
  • Salim Syed from Mizuho set a target price of $121.0 on 12/08/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles